HOME (首页)www.epgonline.orgDRUGS (医学数据)www.epgonline.orgDISEASE KNOWLEDGE (教育)www.epgonline.orgGUIDELINES (医疗指南)www.epgonline.orgTRIALS (临床试验)
Members
Username/Email

Password



EPG News Feed Medical News
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Frequent Searches:
Search
Languages

Medical News Headlines
Thrombosis risk may be raised by cancer drugs
Cancer patients receiving drugs to lower the risk of anaemia...
Published Tuesday 01 December 2009

Chemotherapy can result in insomnia
Insomnia occurs in approximately three-quarters of cancer patients who have...
Published Tuesday 01 December 2009

Osteoarthritis risk increased by high exercise levels
Men and women in middle age who exercise on a...
Published Monday 30 November 2009

Cancer genome changes increase cervical cancer relapse risk
Patients with cervical cancer are three to four times more...
Published Sunday 29 November 2009

More Medical News
Languages

Meningitis

Please note- The EPG Meningitis Knowledge Centre is for Doctors and other Healthcare Professionals.

Meningitis is usually caused by bacteria or viruses but may also be caused by fungi and amoebae.  The severity of the disease is dependent on the causal agent.

Meningitis Knowledge Centre

The main causes of meningitis include:

- Bacterial meningitis:  Many different bacteria may cause meningitis but those with the highest incidence are Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae.

- Neonatal meningitis: Some forms of meningitis predominantly affect neonates, as newborn babies have immature immune systems and so are particularly susceptible to infection.

- Viral: Viral or ‘aseptic’ meningitis is the most common type of meningitis.  It can be very debilitating but is generally far less severe than bacterial meningitis and is rarely fatal.

- Other: Viruses and bacteria are the most common causes of meningitis; however other organisms, such as fungi and amoeba, may also cause this disease, although these cases are extremely rare.

There are several risk factors associated with meningitis and the majority of organisms that cause meningitis are transmitted from person to person via droplets of respiratory or throat secretions.

Meningitis and septicaemia are often difficult to recognise at first as the early symptoms and signs of these two diseases can be mistaken for other, more common diseases. Both are life-threatening conditions which require urgent medical attention and immediate treatment with antibiotics.

Vaccination is the most effective method of preventing meningitis.  However, there is no single vaccine that protects against all forms of the disease.  

Enter the Meningitis Knowledge Centre

What’s in the Meningitis Knowledge Centre?

DISEASE KNOWLEDGE 教育 – evidence based education and clinical tools written for doctors and physicians
More Results Drugs Relating To meningitis

  • KEFADIM - 47.03%
    ... Gynaecological infections Intra-abdominal infections, including peritonitis Septicaemia Central nervous system infections, including meningitis. In meningitis, it is recommended that the results of a sensitivity test are known before treatment with ceftazidime as a single agent. Kefadim may be used ...


  • FLOXAPEN Syrup - 46.1%
    ... and externa, Tonsillitis, Quinsy Other infections caused by Floxapen-sensitive organisms: Osteomyelitis, Urinary tract infection, Enteritis, Meningitis, Endocarditis, Septicaemia Floxapen is also indicated for use as a prophylactic agent during major surgical procedures when appropriate; for example ...


  • PREVENAR SUSPENSION FOR INJECTION - 46.1%
    Active immunisation against invasive disease (including sepsis, meningitis, bacteraemic pneumonia, bacteraemia) caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F and 23F in: - infants and young children from 2 months of age to 2 years of age - previously unvaccinated children aged ...


  • MENGIVAC (A+C) - 46.1%
    Active immunisation against Types A and C meningitis ...


  • AC VAX - 46.1%
    Active immunisation against Types A and C meningitis ...


  • MENINGITEC - 46.1%
    Active immunisation of children from 2 months of age, adolescents and adults for the prevention of invasive disease caused by Neisseria meningitis serogroup C. The use of Meningitec should be determined on the basis of official recommendations ...


FEATURES

DRUG UPDATES Drug updates feed

EMAIL BULLETIN

DISEASE CENTRES Disease Centres feed

MEDICAL NEWS EPG News Feed

RESEARCH

GOOGLE SEARCH

GUIDELINES UK Drug Data Feed

Medicine 医学 UK Drug Data Feed